Boditech Med

Boditech Med EBIT per Share

The EBIT per Share of Boditech Med (206640.KQ) as of Nov 4, 2026 is 1,333.17 KRW. In the previous year, EBIT per Share was 1,182.27 KRW — a change of 12.76% (higher).

EBIT per Share

1,333.17KRW

YoY

12.76%

Last updated:

EBIT per Share of Boditech Med is 2025 1,333.17 KRW. EBIT per Share of Boditech Med was 2024 1,182.27 KRW. It decreases by 12.76% higher compared to the previous year.

The Boditech Med EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2019
646.82 KRW
Jan 1, 2020
2,759.61 KRW
Jan 1, 2021
2,295.47 KRW
Jan 1, 2022
1,122.92 KRW
Jan 1, 2023
1,310.74 KRW
Jan 1, 2024
1,182.27 KRW
Jan 1, 2025
1,333.17 KRW
Jan 1, 2026 (e)
2,470.75 KRW
The Boditech Med EBIT per Share history
YEAREBIT per ShareYoY
est2,470.75KRW+85.33%
1,333.17KRW+12.76%
1,182.27KRW-9.80%
1,310.74KRW+16.73%
1,122.92KRW-51.08%
2,295.47KRW-16.82%
2,759.61KRW+326.64%
646.82KRW-3,518.84%
-18.92KRW-60.82%
-48.29KRW-108.90%
542.89KRW-4.12%
566.22KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Boditech Med Stock analysis

What does Boditech Med do? Boditech Med, Inc. generates revenue through the manufacture and sale of in-vitro diagnostics analyzers and reagents, including antigen diagnostic kits, cancer diagnostic kits, and drug concentration diagnostic kits. The company serves domestic and overseas markets with its products, focusing on diagnostic solutions for healthcare providers and laboratories. Its product portfolio targets medical professionals seeking reliable testing tools for disease detection and treatment monitoring. The firm's primary customers are healthcare institutions and diagnostic laboratories that require specialized testing equipment and consumables. By offering a range of diagnostic kits for various medical applications, Boditech Med addresses the needs of both local and international clients in the healthcare sector. The company's products are designed to support clinical decision-making through accurate and efficient diagnostic processes. Boditech Med is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Boditech Med stock

EBIT per Share of Boditech Med is 1,333.17 KRW in 2025.

EBIT per Share of Boditech Med changed from 1,182.27 KRW to 1,333.17 KRW, representing a 12.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Boditech Med since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Boditech Med

All Key Metrics — Boditech Med